Suggestions
Lisa Conmy
Partner at Foley & Lardner LLP
Lisa Conmy is a partner at Foley & Lardner, based in the firm's Denver office.1 She is a highly experienced venture finance lawyer who serves as outside General Counsel to a number of privately held companies.14 Lisa is a member of the Transactional & Securities Practices and co-chairs the Private Equity & Venture Capital Practices at Foley & Lardner.1
Conmy counsels clients on business formation, corporate governance, general corporate matters, and commercial contracts.1 She focuses on representing venture capital funds and companies in venture capital financings, venture debt, and exit transactions.1 Her clients operate in the technology, food and beverage, health care, manufacturing, and insurance industries.1
Before joining Foley, Lisa was an associate in Silicon Valley, where she concentrated on mergers and acquisitions and represented venture funds and emerging growth companies in fundraising and exit transactions.1 She was recognized as an Illinois Super Lawyers–Rising Stars® in 2015 and 2016.1 The Legal 500 also recognized her in the area of finance – project finance (2013), mergers, acquisitions and buyouts (2014), and M&A/corporate and commercial – venture capital and emerging companies (2015).1
Lisa earned a Bachelor of Science in Finance from Indiana University Bloomington (1994-1998) and a Doctor of Law (J.D.) from Northwestern University School of Law (1998-2001).2 She is admitted to practice in Illinois, California, and Colorado.3
Highlights
What will be the biggest gamer-changer in manufacturing in the next five years? Join me in Chicago on Thursday, April 25 for Brainwaves: Digital Disruption in Manufacturing, where we'll explore the impact of advanced technologies on manufacturing. We still have some spots available — let me know if you're interested in attending, or email my colleagues at [email protected] #FoleyBrainwaves #Manufacturing #DigitalDisruption #InnovativeTechnology
Kyle Faget joined STAT+ to discuss a letter recently issued by the FDA to a #digitalhealth heart monitoring company and the consequences it may foreshadow for the expanding intersection of health care and technology. #technology #healthcare
